Authors:
SINGH M
LI XM
WANG HY
MCGEE JP
ZAMB T
KOFF W
WANG CY
OHAGAN DT
Citation: M. Singh et al., CONTROLLED-RELEASE MICROPARTICLES AS A SINGLE-DOSE DIPHTHERIA TOXOID VACCINE - IMMUNOGENICITY IN SMALL ANIMAL-MODELS, Vaccine, 16(4), 1998, pp. 346-352
Authors:
ISHII N
FUKUSHIMA J
KANEKO T
OKADA E
TANI K
TANAKA SI
HAMAJIMA K
XIN KQ
KAWAMOTO S
KOFF W
NISHIOKA K
YASUDA T
OKUDA K
Citation: N. Ishii et al., CATIONIC LIPOSOMES ARE A STRONG ADJUVANT FOR A DNA VACCINE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, AIDS research and human retroviruses, 13(16), 1997, pp. 1421-1428
Authors:
KEEFER MC
WOLFF M
GORSE GJ
GRAHAM BS
COREY L
CLEMENTSMANN ML
VERANIKETTER N
ERB S
SMITH CM
BELSHE RB
WAGNER LJ
MCELRATH MJ
SCHWARTZ DH
FAST P
CHARRON K
REYNOLDS MJ
ZIMMERMAN E
JONES K
HARRIS M
FREY SE
KENNEDY DJ
ISRAEL H
BERRY C
READ B
SPITZ T
PACATTE T
DOLIN R
REICHMAN RC
LAMBERT J
DEMETER L
ROBERTS NJ
PUGLIESE M
BERGER D
BURKE J
SCOTT T
BLACKSTONE E
WRIGHT PF
BRAEUNER M
RYBCZYK GK
CRUMBO K
BATTLE W
CORNELL R
OWENS D
JENNINGS M
HARBISON MA
HENSMAN BJ
BARR P
STABLEIN DM
VOSS T
PALLAS S
LOMAX N
KOFF W
LAWRENCE D
JOHNSTON M
SAVARESE B
WESCOTT SL
Citation: Mc. Keefer et al., SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP, AIDS research and human retroviruses, 13(14), 1997, pp. 1163-1177
Authors:
SINGH M
LI XM
MCGEE JP
ZAMB T
KOFF W
WANG CY
OHAGAN DT
Citation: M. Singh et al., CONTROLLED-RELEASE MICROPARTICLES AS A SINGLE-DOSE HEPATITIS-B VACCINE - EVALUATION OF IMMUNOGENICITY IN MICE, Vaccine, 15(5), 1997, pp. 475-481
Authors:
SINGH M
HIOE C
QIU H
LI XM
WANG CY
KOFF W
ZAMB T
NIXON DF
Citation: M. Singh et al., CTL INDUCTION USING SYNTHETIC PEPTIDES DELIVERED IN EMULSIONS - CRITICAL ROLE OF THE FORMULATION PROCEDURE, Vaccine, 15(16), 1997, pp. 1773-1778
Authors:
SINGH M
MCGEE JP
LI XM
KOFF W
ZAMB T
WANG CY
OHAGAN DT
Citation: M. Singh et al., BIODEGRADABLE MICROPARTICLES WITH AN ENTRAPPED BRANCHED OCTAMERIC PEPTIDE AS A CONTROLLED-RELEASE HIV-1 VACCINE, Journal of pharmaceutical sciences, 86(11), 1997, pp. 1229-1233
Authors:
SINGH M
LI XM
WANG HY
MCGEE JP
ZAMB T
KOFF W
WANG CY
OHAGAN DT
Citation: M. Singh et al., IMMUNOGENICITY AND PROTECTION IN SMALL-ANIMAL MODELS WITH CONTROLLED-RELEASE TETANUS TOXOID MICROPARTICLES AS A SINGLE-DOSE VACCINE, Infection and immunity, 65(5), 1997, pp. 1716-1721
Authors:
HIOE CE
QIU H
CHEND PD
BIAN ZN
LI ML
LI J
SINGH M
KUEBLER P
MCGEE P
OHAGAN D
ZAMB T
KOFF W
ALLSOPP C
WANG CY
NIXON DF
Citation: Ce. Hioe et al., COMPARISON OF ADJUVANT FORMULATIONS FOR CYTOTOXIC T-CELL INDUCTION USING SYNTHETIC PEPTIDES, Vaccine, 14(5), 1996, pp. 412-418
Authors:
POTTS BJ
FIELD K
MASCOLA J
WANG CY
KOFF W
Citation: Bj. Potts et al., NEUTRALIZATION OF PRIMARY FIELD ISOLATES OF HIV-1 FROM GLOBALLY DIVERSE CLADES, AIDS research and human retroviruses, 10, 1994, pp. 190000056-190000056
Authors:
BELSHE RB
CLEMENTS ML
DOLIN R
GRAHAM BS
MCELRATH J
GORSE GJ
SCHWARTZ D
KEEFER MC
WRIGHT P
COREY L
BOLOGNESI DP
MATTHEWS TJ
STABLEIN DM
OBRIEN FS
EIBL M
DORNER F
KOFF W
Citation: Rb. Belshe et al., SAFETY AND IMMUNOGENICITY OF A FULLY GLYCOSYLATED RECOMBINANT GP160 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VACCINE IN SUBJECTS AT LOW-RISK OF INFECTION, The Journal of infectious diseases, 168(6), 1993, pp. 1387-1395